Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1017239.RAvUlMn52HKNrSsCIrwlbu4cGrICG32rLPzG8BLt_MnLE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1017239.RAvUlMn52HKNrSsCIrwlbu4cGrICG32rLPzG8BLt_MnLE130_assertion type Assertion NP1017239.RAvUlMn52HKNrSsCIrwlbu4cGrICG32rLPzG8BLt_MnLE130_head.
- NP1017239.RAvUlMn52HKNrSsCIrwlbu4cGrICG32rLPzG8BLt_MnLE130_assertion description "[enhanced mRNA expression of known osteoporosis-associated genes (LRP5, RUNX2, COL1A1) and of genes involved in osteoclastogenesis (CSF1, PTH1R), but most notably of genes coding for inhibitors of WNT and BMP signaling, such as Sclerostin and MAB21L2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1017239.RAvUlMn52HKNrSsCIrwlbu4cGrICG32rLPzG8BLt_MnLE130_provenance.
- NP1017239.RAvUlMn52HKNrSsCIrwlbu4cGrICG32rLPzG8BLt_MnLE130_assertion evidence source_evidence_literature NP1017239.RAvUlMn52HKNrSsCIrwlbu4cGrICG32rLPzG8BLt_MnLE130_provenance.
- NP1017239.RAvUlMn52HKNrSsCIrwlbu4cGrICG32rLPzG8BLt_MnLE130_assertion SIO_000772 23028809 NP1017239.RAvUlMn52HKNrSsCIrwlbu4cGrICG32rLPzG8BLt_MnLE130_provenance.
- NP1017239.RAvUlMn52HKNrSsCIrwlbu4cGrICG32rLPzG8BLt_MnLE130_assertion wasDerivedFrom befree-2016 NP1017239.RAvUlMn52HKNrSsCIrwlbu4cGrICG32rLPzG8BLt_MnLE130_provenance.
- NP1017239.RAvUlMn52HKNrSsCIrwlbu4cGrICG32rLPzG8BLt_MnLE130_assertion wasGeneratedBy ECO_0000203 NP1017239.RAvUlMn52HKNrSsCIrwlbu4cGrICG32rLPzG8BLt_MnLE130_provenance.